
|
Ara Parseghian Medical Research Foundation
Currently Funded Grants as of 7/1/09
- Lina Abi-Mosleh, Ph.D - NP-C Fellowship – UT Southwestern Medical Center at Dallas
- Eric Barker Ph.D. & Val Watts Ph.D. – Associate Professors, Medicinal Chemistry and Molecular Pharmacology, Purdue University – TITLE: “Drug Screening Assay Development for Niemann-Pick Disease Type C”
- Lawrence Goldstein, Ph.D. – Professor, PI and Director of the University of California, San Diego Stem Cell Program – TITLE: “Unraveling the Role of Cholesterol in Neurodegeneration: a Stem Cell Based Model of NP-C Disease”
- Paul Helquist, Ph.D. and Olaf Wiest, Ph.D. – Professors, Chemistry and Biochemistry, University of Notre Dame – TITLE: “Development of Therapeutic Agents for NPC1 Disease”
- Paul Helquist, Ph.D. – Professor, Chemistry and Biochemistry, University of Notre Dame – Targeted collaboration with the Maxfield laboratory. TITLE: “Tissue Culture Models for Assessing NPC Therapies”
- Barbara Karten, Ph.D. – Assistant Professor, Biochemistry and Molecular Biology, Dalhousie University, Canada – TITLE: “Effects of changes in cholesterol and energy homeostasis on NPC1–deficient neurons”
- Andres Klein – NP-C Fellowship – TITLE: “Understanding Niemann-Pick Type C disease-Pick type C Neurodegeneration”
- Guosheng Liang, Ph.D. – Assistant Professor, Molecular Genetics, UT Southwestern Medical Center at Dallas – TITLE: “Generation of Mouse Models to Elucidate the Tissue and Cell Type Specific Function of NPC1”
- Peter Lobel, Ph.D. – Professor, Pharmacology, Robert Wood Johnson Medical School – TITLE: "Molecular Characterization NPC2 Disease"
- Frederick Maxfield, Ph.D. – Professor and Chairman, Biochemistry, Weill Medical College of Cornell University – TITLE: “Modifiers of Cholesterol Transport in NP-C Cells”
- Frederick Maxfield, Ph.D. – Professor and Chairman, Biochemistry, Weill Medical College of Cornell University – Targeted collaboration with the Helquist laboratory. TITLE: “Tissue Culture Models for Assessing NPC Therapies”
- Daniel S. Ory, M.D. –Professor of Medicine, Cell Biology and Physiology, Internal Medicine, Washington University – TITLE: “Validation of Oxidative Stress biomarkers for Niemann-Pick Type C Disease”
- Suzanne Pfeffer, Ph.D. – Professor, Biochemistry, Stanford University School of Medicine – TITLE: “Molecular Analysis of NPC1 Protein”
- Charina Ramirez M.D.– NP-C Fellowship – TITLE: “Post-Doctoral Research Fellowship for Work on Niemann-Pick Type C Disease”
- Joyce Repa, Ph.D. – Assistant Professor, Physiology, UT Southwestern Medical Center at Dallas – TITLE: “Nuclear Orphan Receptors as Targets for the Treatment of NP-C Disease”
- Heiko Runz, M.D. – Physician Scientist, Institute of Human Genetics, University of Heidelberg, Germany – TITLE: “Identification and Functional Characterization of Novel Genes Modifying NP-C Disease”
- Matthew Scott, Ph.D. – Professor, Developmental Biology, Stanford University School of Medicine – TITLE: "Analyzing Tissue-specific Functions of NPC1"
- Judith Storch, Ph.D. – Professor, Nutritional Sciences, Rutgers University – TITLE: "Cholesterol Transport by NPC2 and Cyclodextrins"
- Kanagaraj Subramanian, Ph.D. – NP-C Fellowship, Scripps Research Institute – TITLE: “A Systems –Wide Roadmap of NPC1 Mutant Trafficking In The Neuron” (Co-funded by DART – Dana’s Angels Research Trust)
- Jean Vance Ph.D. – Professor of Medicine, University of Alberta, Canada – TITLE: “Mobilization of Stored Cholesterol in NPC1-deficient Neurons and Glial Cells”
- Charles Vite, D.V.M., Ph.D. – Associate Professor, Neurology, University of Pennsylvania School of Veterinary Medicine – TITLE: “Evaluating Treatment Strategies for Feline NP-C Disease”
- Hongyuan Yang, Ph.D. – Senior Lecturer, Biotechnology and Biomolecular Sciences, University of New South Wales, Australia – TITLE: “Sterol-dependent Interactions between Ncr1p and Osh Proteins in the Budding Yeast”
- Michael L. Yang - NP-C Fellowship – UT Southwestern Medical Center at Dallas
- Nicole Yanjanin, RN – Nurse Coordinator – NP-C Natural History Study, National Institutes of Health (Co-funded by DART – Dana’s Angels Research Trust
Return to Research Section
|